Portal de recerca
ESTUDIO DE GRUPOS PARALELOS, ABIERTO Y MULTICENTRICO DE 5 AÑOS DE SEGUIMIENTO, CON EL OBJETIVO DE DEMOSTRAR LA SEGURIDAD A CORTO Y LARGO PLAZO ELIDEL (PIMECROLIMUS ASM981) CREMA AL 1 % EN EL TRATAMIENTO DE LA DERMATITIS ATOPICA LEVE-MODRADA EN LACTANES (3-<12 MESES DE EDAD).
Dades bàsiques
- Protocol:
- CASM981C2306
- EURDRACT:
- NO ENCUENTRO
- NCT:
- Centre:
- Any inici:
- Any de finalització:
Documents
- No hi ha documents
Participants
Finançadors - Promotors
NOVARTIS FARMACEUTICA, S.A.
Resultats de l'Assaig Clínic
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?
Nieto, Antonio; (...); Luis Subiza, Jose
Article. 10.1097/ACI.0000000000000854. 2022
First-in-human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy.
Nieto, Antonio; (...); Casanovas, Miguel
Article. 10.1111/all.15374. 2022
Growth, Safety and Tolerance in Infants Fed Rice Protein Hydrolysate Formula: The GRITO Randomised Controlled Trial.
Lemoine, Anais; (...); Navas-Lopez, Victor Manuel
Article. 10.3390/nu17010162. 2024
Validation of the food allergy independent measure and the EuroPrevall food allergy quality of life questionnaire for children 8-12 years translated into Spanish.
Jang, Dah-Tay; (...); Mazon, Angel
Article. 10.15586/aei.v50i1.467. 2022